Diabetes can silently damage the blood vessels in your retina for years before you notice anything wrong. Regular screening is not optional. Full stop. It is what stands between manageable disease and permanent vision loss.
Diabetic retinopathy is a complication of diabetes that affects the tiny blood vessels supplying the retina at the back of the eye. Over time, high blood sugar levels damage these vessels: they leak, swell, or grow abnormally, gradually disrupting the retina’s ability to function. It is the leading cause of preventable blindness in working-age adults in developed countries. By the time vision is affected, significant and often irreversible damage has already occurred. This is a condition where screening and early intervention make an enormous difference.
What You Need to Know About Diabetic Retinopathy
- Diabetic retinopathy affects around 1 in 3 people with diabetes and is present in the majority of those who have had diabetes for 20 years or more
- In the early stages it causes no symptoms at all. Vision loss is a late sign, which is why annual retinal screening matters so much
- Both type 1 and type 2 diabetes can cause retinopathy. Duration of diabetes and blood sugar control are the strongest risk factors
- Tight control of blood glucose, blood pressure, and blood lipids slows progression substantially
- Sight-threatening disease is highly treatable with anti-VEGF injections and laser, particularly when caught early
- Smoking worsens diabetic vascular disease throughout the body. Stopping protects your eyes as well as everything else
The Stages of Diabetic Retinopathy
Diabetic retinopathy progresses through well-defined stages. Knowing where you are helps make sense of what your ophthalmologist is monitoring and why the frequency of your appointments matters.
Mild non-proliferative DR (NPDR)
Tiny balloon-like swellings called microaneurysms appear in the walls of the retinal vessels. The earliest detectable sign. Vision is typically completely normal. Optimising blood glucose, blood pressure, and cholesterol is the main intervention at this stage, alongside annual monitoring.
Moderate non-proliferative DR
More vessels become damaged and begin to leak. Dot and blot haemorrhages appear on the retina alongside hard exudates (deposits of leaked lipids). Vision may still be normal unless the leakage affects the central macula. Monitoring becomes more frequent and systemic risk factor control more important.
Severe non-proliferative DR
Many more vessels are blocked, depriving areas of retina of their blood supply. The retina responds by sending signals for new vessel growth. High risk of progressing to proliferative disease within a year. Treatment is often initiated here and close monitoring is essential.
Proliferative DR (PDR)
Abnormal new blood vessels grow on the retinal surface and into the vitreous. These fragile vessels bleed easily, causing sudden vision loss from vitreous haemorrhage. Scar tissue can pull on the retina, leading to tractional retinal detachment. PDR requires prompt treatment and is sight-threatening.
Diabetic Macular Edema
Diabetic macular edema (DME) is the most common cause of vision loss in diabetic retinopathy and can occur at any stage, not just late disease. Damaged blood vessels leak fluid into the macula, the central area of the retina responsible for sharp detail vision. The fluid causes the macula to swell, blurring and distorting central vision. It is now highly treatable with anti-VEGF injections, and most patients who receive prompt treatment maintain or improve their vision.
Risk Factors and Prevention
Blood sugar control
Duration of diabetes and the level of blood glucose control over time are the two most powerful determinants of whether retinopathy develops and how quickly it progresses. Every reduction in HbA1c reduces the risk. Intensive glucose control in the early years of diabetes substantially reduces the lifetime risk of sight-threatening retinopathy, an effect that persists for years even if control later deteriorates. This is sometimes called the legacy effect, and it is one of the most compelling arguments for tight control from the start.
Blood pressure and cholesterol
High blood pressure accelerates retinal vessel damage independently of blood glucose levels. Tight blood pressure control reduces the risk of retinopathy progression by around a third. That number is worth sitting with. High cholesterol is associated with more hard exudate formation and macular involvement. Managing all three risk factors simultaneously gives the best protection.
Pregnancy
Pregnancy can cause rapid progression of diabetic retinopathy, particularly in women with pre-existing disease. Women with diabetes planning a pregnancy should have a retinal examination early and be monitored more frequently throughout. This is not a reason to avoid pregnancy, but it should be planned carefully with medical support.
Treatment
Anti-VEGF injections
Anti-VEGF medications injected into the vitreous cavity are the first-line treatment for DME and for proliferative retinopathy with active new vessel growth. They block the signal that drives both the leakage and abnormal vessel growth. Treatment typically involves a loading phase of monthly injections, then a maintenance schedule based on retinal response at each visit assessed with an OCT scan.
Laser treatment
Pan-retinal photocoagulation (PRP) laser applies burns to the peripheral retina, reducing the retina’s demand for oxygen and suppressing the stimulus for new vessel growth. PRP has largely been supplemented by anti-VEGF injections in many cases but remains important for patients who cannot attend regularly for injections or when injections alone are insufficient.
Vitreoretinal surgery
In advanced PDR complicated by non-clearing vitreous haemorrhage or tractional retinal detachment, vitreoretinal surgery may be needed. The surgeon removes the blood-filled vitreous and any fibrovascular scar tissue pulling on the retina. Outcomes depend heavily on how much retinal damage occurred before surgery. Getting to this point is precisely what the whole treatment pathway aims to prevent.
The Most Important Thing You Can Do: Attend Your Screening
Annual diabetic eye screening exists for one reason: to detect retinopathy before it causes symptoms, when treatment is most effective and vision loss most preventable. Diabetic retinopathy causes no pain and no noticeable vision change in its early and treatable stages. By the time something feels wrong, the opportunity for the simplest intervention has often passed.
Missing screening appointments is one of the most significant risk factors for preventable blindness from diabetic retinopathy. If you have diabetes and haven’t had a retinal photograph in the past year, booking one now is the single most important action you can take for your eyesight. If you were referred for hospital review and haven’t yet attended, please don’t delay further.
Screening is not the same as a standard optician’s check. It specifically photographs the retina to detect early signs that cannot be seen without dilating the pupil and examining the back of the eye in detail.
Seek Urgent Eye Care the Same Day If You Notice
- A sudden increase in floaters or new dark spots in your vision
- A dark curtain, shadow, or veil appearing across part of your visual field
- A sudden significant loss of vision in one eye
- Vision that has become noticeably and rapidly worse over hours or days
These symptoms can indicate vitreous haemorrhage or retinal detachment, both serious complications of proliferative diabetic retinopathy. Don’t wait to see if they improve. Contact your eye unit or an emergency eye service the same day.
Frequently Asked Questions About Diabetic Retinopathy
-
My vision is fine. Do I still need eye screening?
Absolutely. This is the single most important message in diabetic eye care. Diabetic retinopathy can be at a moderately advanced stage and still cause no noticeable change in vision. The damage accumulates silently. Annual screening catches it at the stage when treatment is simplest and outcomes are best.
-
My diabetes is well controlled. Can I still get retinopathy?
Yes, though good control substantially reduces the risk and slows progression. Duration of diabetes matters alongside control: someone who has had well-controlled diabetes for 25 years still has a meaningful cumulative risk. Good control is absolutely the right goal, but it doesn’t eliminate the need for annual retinal screening. Both are necessary.
-
Will I go blind from diabetic retinopathy?
Most people with diabetic retinopathy don’t go blind. That’s worth saying clearly, because a lot of newly diagnosed patients assume the worst. Regular screening and appropriate treatment when needed make the difference. Modern treatments for DME and proliferative retinopathy are highly effective when started at the right time. The patients at greatest risk of blindness are those who don’t attend screening, present late with advanced disease, or have poor systemic risk factor control over many years.
-
Are the injections painful?
For patients who need injections long-term — and many people with diabetic retinopathy do — the procedure quickly becomes just another part of the schedule. The eye is numbed beforehand, the injection takes a few seconds, and most people feel nothing beyond mild pressure. The first one is almost always the most daunting. By the third or fourth, most patients barely give it a second thought. The grittiness that follows for a day or two, and the red patch on the white of the eye that looks much worse than it is, are entirely normal and temporary.
-
How often do I need injections?
Treatment schedules vary depending on how the retina responds. Most patients start with monthly injections for a loading phase, then move to a schedule adjusted at each visit based on the OCT findings. Some achieve stable disease and can extend intervals considerably. Others need ongoing treatment for years. Missing appointments risks fluid returning and vision declining, so consistent attendance matters even when the eye feels comfortable.
-
Can improving my blood sugar reverse retinopathy?
In the very early stages, better glucose control can slow or stabilize mild retinopathy. Established retinal damage cannot be reversed by control alone. One genuinely counterintuitive point: a very rapid improvement in blood glucose can temporarily worsen retinopathy before it stabilizes. That shouldn’t discourage better control, but it does mean such transitions should be monitored closely by your eye team.
If you would like to learn more, the American Academy of Ophthalmology’s diabetic retinopathy page offers a clear overview of causes, symptoms, treatment, and how diabetes can affect the retina and threaten vision.